Join Fenwick and Deloitte for an in-depth discussion on critical financial, accounting, and legal compliance considerations for life sciences companies preparing for an IPO. Our panel will cover key topics, including Form S-1 preparation and coordination, the audit uplift process, recent areas of SEC focus, SOX compliance planning, and insights from Deloitte’s national office on emerging audit concerns. Don't miss this opportunity to gain practical guidance on navigating the IPO process effectively.